Zogenix (ZGNX) Zohydro ER Fails to Win FDA Panel Backing
Zogenix (Nasdaq: ZGNX) Zohydro ER fails to win FDA panel backing.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shire plc (SHPG) Said Considering Bid for NPS Pharma (NPSP)
- Seattle Genetics (SGEN) Initiates SGN-CD33A Combo Phase 1 in Newly Diagnosed AML
- Deere & Co. (DE) to Sell Crop Insurance Unit
Create E-mail Alert Related CategoriesCorporate News, FDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!